Peroxisome proliferator activated receptor (PPAR)γ/retinoid X receptor (PPARγ/RXR) agonists may induce differentiation in osteosarcoma, despite critical blocks to the normal bone morphogenetic protein (BMP)-regulated pathways. The gene discussed is PPARG; the disease is osteosarcoma.